hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients

hERG1 and HIF-2α Behave as Biomarkers of Positive Response to Bevacizumab in Metastatic Colorectal Cancer Patients

Background: In search of novel biomarkers of response to bevacizumab in metastatic colorectal cancer (mCRC), we analyzed the expression and prognostic role of several proteins related to angiogenesis. Methods: A retrospective, multicenter study on 80 surgical samples from mCRC patients treated in fi...

Full description

Bibliographic Details
Main Authors:	Jessica Iorio, Elena Lastraioli, Lorenzo Tofani, Giulia Petroni, Lorenzo Antonuzzo, Luca Messerini, Giuseppe Perrone, Damiano Caputo, Maria Francesconi, Maria Michelina Amato, Moris Cadei, Giuseppina Arcangeli, Vincenzo Villanacci, Luca Boni, Roberto Coppola, Francesco Di Costanzo, Annarosa Arcangeli
Format:	Article
Language:	English
Published:	Elsevier 2020-03-01
Series:	Translational Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523319303766

Similar Items

hERG1 Potassium Channel Expression in Colorectal Adenomas: Comparison with Other Preneoplastic Lesions of the Gastrointestinal Tract
by: Elena Lastraioli, et al.
Published: (2022-03-01)

The Interaction between hERG1 and β1 Integrins Modulates hERG1 Current in Different Pathological Cell Models
by: Ginevra Chioccioli Altadonna, et al.
Published: (2022-11-01)

RETRACTED ARTICLE: hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
by: Olivia Crociani, et al.
Published: (2013-11-01)

Retraction Note: hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
by: Olivia Crociani, et al.
Published: (2025-01-01)

High throughput clone screening on overexpressed hERG1 and Kv1.3 potassium channels using ion channel reader (ICR) label free technology
by: Alberto Montalbano, et al.
Published: (2023-10-01)

The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells
by: Pillozzi, Serena, et al.
Published: (2020)

Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer
by: Claudia Duranti, et al.
Published: (2025-02-01)

Transcriptomic data of bevacizumab-adapted colorectal adenocarcinoma cells HCT-116
by: Sala Cesare, et al.
Published: (2023-06-01)

The effect of isoliquiritigenin on the hERG potassium channel
by: Mujahid, M, et al.
Published: (2020)

An Insight into the Potassium Currents of hERG and Their Simulation
by: Rolando Guidelli
Published: (2023-04-01)

Cardiac safety assessment of a novel recombinant bispecific antibody targeting the ether-à-go-go related gene 1 (hERG1)-β1 integrin macromolecular complex
by: Lorenzo Santini, et al.
Published: (2023-09-01)

Corrigendum to “Transcriptomic data of Bevacizumab-adapted colorectal adenocarcinoma cells HCT-116” [Data In Brief, Volume 48, (Available online 17 March 2023) 1-9/Article 109069]
by: Cesare Sala, et al.
Published: (2023-08-01)

Ion conduction through the hERG potassium channel.
by: Luisa Ceccarini, et al.
Published: (2012-01-01)

Stereoselective inhibition of the hERG1 potassium channel
by: Liliana eSintra Grilo, et al.
Published: (2010-11-01)

Construction of an integrated database for hERG blocking small molecules.
by: Tomohiro Sato, et al.
Published: (2018-01-01)

Inhibition of hERG by ESEE suppresses the progression of colorectal cancer
by: Jufeng Wan, et al.
Published: (2024-12-01)

Up-regulation of hERG K⁺ channels by B-RAF.
by: Tatsiana Pakladok, et al.
Published: (2014-01-01)

Molecular Determinants of hERG Channel Block by Terfenadine and Cisapride
by: Kaichiro Kamiya, et al.
Published: (2008-01-01)

Computational determination of hERG-related cardiotoxicity of drug candidates
by: Hyang-Mi Lee, et al.
Published: (2019-05-01)

Data on the construction of a recombinant HEK293 cell line overexpressing hERG potassium channel and examining the presence of hERG mRNA and protein expression
by: Yi, Fan Teah, et al.
Published: (2017)

Data on the construction of a recombinant HEK293 cell line overexpressing hERG potassium channel and examining the presence of hERG mRNA and protein expression
by: Yi Fan Teah, et al.
Published: (2017-10-01)

Rapid characterisation of hERG channel kinetics II: temperature dependence
by: Lei, CL, et al.
Published: (2019)

Hydroxychloroquine induces long QT syndrome by blocking hERG channel
by: Zhao Xin, et al.
Published: (2023-05-01)

The Study on the hERG Blocker Prediction Using Chemical Fingerprint Analysis
by: Kwang-Eun Choi, et al.
Published: (2020-06-01)

Structural modeling of hERG channel–drug interactions using Rosetta
by: Aiyana M. Emigh Cortez, et al.
Published: (2023-11-01)

Noncanonical electromechanical coupling paths in cardiac hERG potassium channel
by: Carlos A. Z. Bassetto, et al.
Published: (2023-02-01)

Structural modeling of the hERG potassium channel and associated drug interactions
by: Jan Maly, et al.
Published: (2022-09-01)

A Receptor-Independent Effect of Estrone Sulfate on the hERG Channel
by: Shoko Kakusaka, et al.
Published: (2009-01-01)

hERG K+ Channels Promote Survival of Irradiated Leukemia Cells
by: Daniela Palme, et al.
Published: (2020-04-01)

Berberine Induces hERG Channel Deficiency through Trafficking Inhibition
by: Kaiping Zhang, et al.
Published: (2014-08-01)

AttenhERG: a reliable and interpretable graph neural network framework for predicting hERG channel blockers
by: Tianbiao Yang, et al.
Published: (2024-12-01)

KV11.1 Potassium Channel and the Na+/H+ Antiporter NHE1 Modulate Adhesion-Dependent Intracellular pH in Colorectal Cancer Cells
by: Jessica Iorio, et al.
Published: (2020-06-01)

Mathematical modelling of hERG channel kinetics using sinusoidal voltage protocols
by: Beattie, K, et al.
Published: (2017)

Purification and structural characterization of the voltage-sensor domain of the hERG potassium channel
by: Ng, Hui Qi, et al.
Published: (2013)

Characterization of amiodarone action on currents in hERG-T618 gain-of-function mutations
by: Lin Min, et al.
Published: (2023-11-01)

Ensemble of structure and ligand-based classification models for hERG liability profiling
by: Serena Vittorio, et al.
Published: (2023-03-01)

A Heterozygous Missense hERG Mutation Associated with Early Repolarization Syndrome
by: Yun-Jiu Cheng, et al.
Published: (2018-11-01)

Effects of an hERG Activator, ICA-105574, on Electrophysiological Properties of Canine Hearts
by: Mahoko Asayama, et al.
Published: (2013-01-01)

Inhibition of the hERG Potassium Channel by a Methanesulphonate-Free E-4031 Analogue
by: Matthew V. Helliwell, et al.
Published: (2023-08-01)

High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition
by: Shagun Krishna, et al.
Published: (2022-01-01)